Skip to main content

Obesity, Metabolic Syndrome, and Stones

  • Chapter
  • First Online:
  • 1606 Accesses

Abstract

Obesity (body mass index (BMI) above 30 kg/m2) has become an epidemic condition that affects 10–27% of men and up to 38% of women in European countries. In the United States, more than 5% of the adult population are considered morbidly obese (BMI of 40 kg/m2 or more). Worldwide, more than 300 million people are estimated to be obese. According to recent epidemiologic studies, greater BMI, greater weight, larger waist circumference, and heavy weight gain are independently associated with increased risk for renal stone formation. This appears to be related to two distinct metabolic conditions: (1) Abdominal obesity in the context of the so-called metabolic syndrome predisposes to insulin resistance, which at the renal level appears to cause reduced urinary ammonium excretion and low urine pH. The consequence is an increased risk for uric acid stone formation. (2) Bariatric surgery, more and more popular as the only intervention that facilitates significant weight loss in morbidly obese people, has been shown to increase the risk for calcium oxalate nephrolithiasis. The underlying pathophysiologic mechanisms may be enteric hyperoxaluria due to fat malabsorption or decreased intestinal colonization with oxalate-degrading bacteria.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. DeMaria EJ. Bariatric surgery for morbid obesity. N Engl J Med. 2007;356:2176-2183.

    Article  CAS  PubMed  Google Scholar 

  2. James WPT, Van de Werf F. Obesity management: the cardiovascular benefits. Eur Heart J. 2005;7(Suppl L):L3-L4.

    Article  Google Scholar 

  3. Flum DR, Khan TV, Dellinger EP. Toward the rational and equitable use of bariatric surgery. JAMA. 2007;298:1442. commentary.

    Article  CAS  PubMed  Google Scholar 

  4. Taylor EN, Stampfer MJ, Curhan GC. Obesity, weight gain, and the risk of kidney stones. JAMA. 2005;293:455-462.

    Article  CAS  PubMed  Google Scholar 

  5. Powell CR, Stoller ML, Schwartz BF, et al. Impact of body weight on urinary electrolytes in urinary stone formers. Urology. 2000;55:825-830.

    Article  CAS  PubMed  Google Scholar 

  6. Taylor EN, Curhan GC. Body size and 24-hour urine composition. Am J Kidney Dis. 2006;48:905-915.

    Article  CAS  PubMed  Google Scholar 

  7. Maalouf NM, Sakhaee K, Parks JH, Coe FL, Adams-Huet B, Pak CYC. Association of urinary pH with body weight in nephrolithiasis. Kidney Int. 2004;65:1422-1425.

    Article  PubMed  Google Scholar 

  8. Hess B. Acid-base metabolism: implications for kidney stone formation. Urol Res. 2006;34:134-138.

    Article  CAS  PubMed  Google Scholar 

  9. Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC. Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int. 2003;63:1817-1823.

    Article  PubMed  Google Scholar 

  10. Hesse A, Brändle E, Wilbert, Köhrmann K-U, Alken P. Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 vs. 2000. Eur Urol. 2003;44:709-713.

    Article  CAS  PubMed  Google Scholar 

  11. Alberti KGMM, Zimmet P, Shaw J, for the IDF Epidemiology Task Force Consensus Group. The metabolic syndrome – a new worldwide definition. Lancet. 2005;366:1059-1062.

    Article  Google Scholar 

  12. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287:356-359.

    Article  PubMed  Google Scholar 

  13. West B, Luke A, Durazo-Arvizu RA, Cao G, Shoham D, Kramer H. Metabolic syndrome and self-reported history of kidney stones: the National Health and Nutrition Examination Survey (NHANES III) 1988–1994. Am J Kidney Dis. 2008;51:741-747.

    Article  PubMed  Google Scholar 

  14. Pak CYC, Sakhaee K, Peterson RD, Poindexter JR, Frawley WH. Biochemical profile of idiopathic uric acid nephrolithiasis. Kidney Int. 2001;60:757-761.

    Article  CAS  PubMed  Google Scholar 

  15. Kamel KS, Cheema-Dhadli S, Halperin ML. Studies on the pathophysiology of the low urine pH in patients with uric acid stones. Kidney Int. 2002;61:988-994.

    Article  CAS  PubMed  Google Scholar 

  16. Sakhaee S, Adams-Huet B, Moe OW, Pak CYC. Pathophysiologic basis for normouricosuric uric acid nephrolithiasis. Kidney Int. 2002;62:971-979.

    Article  CAS  PubMed  Google Scholar 

  17. Abate N, Chandalia M, Cabo-Chan AV Jr, Moe OW, Sakhaee K. The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. Kidney Int. 2004;65:386-392.

    Article  CAS  PubMed  Google Scholar 

  18. Grundy SM, Cleeman JI, Daniels SR, et al. American Heart Association; National Heart, Lung, and Blood Institute, et al. Diagnosis and management of the metabolic syndrome: an American heart association/national heart, lung, and blood institute scientific statement. Circulation. 2005;112:2735-2752.

    Article  PubMed  Google Scholar 

  19. Carey DG, Jenkins AB, Campbell LV, Freund J, Chisholm DJ. Abdominal fat and insulin resistance in normal and overweight women: Direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes. 1996;45:633-638.

    Article  CAS  PubMed  Google Scholar 

  20. DeFronzo RE, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;233:E214-E223.

    Google Scholar 

  21. Sinha MK, Collazo-Clavell ML, Rule A, et al. Hyperoxaluric nephrolithiasis is a complication of Roux-en-Y-gastric bypass surgery. Kindey Int. 2007;71:100-107.

    Article  Google Scholar 

  22. DePrisco C, Levine SN. Metabolic bone disease after gastric bypass surgery for obesity. Am J Med Sci. 2005;329:57-61.

    Article  Google Scholar 

  23. Colazzo-Clavell ML, Jiminez A, Hodgson SF, Sarr MG. Osteomalacia after Roux-en-Y-gastric bypass. Endocr Pract. 2004;10:195-198.

    Google Scholar 

  24. Shinogle JA, Owings MF, Kozak LJ. Gastric bypass as treatment for obesity: trends, characteristics, and complications. Obes Res. 2005;13:2202-2209.

    Article  PubMed  Google Scholar 

  25. Nelson WK, Houghton SG, Milliner DS, Lieske JC, Sarr MG. Enteric hyperoxaluria, nephrolithiasis, and oxalate nephropathy: potentially serious and unappreciated complications of Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2005;1:481-485.

    Article  PubMed  Google Scholar 

  26. Asplin JR, Coe FL. Hyperoxaluria in kidney stone formers treated with modern bariatric surgery. J Urol. 2007;177:565-569.

    Article  PubMed  Google Scholar 

  27. Duffey BG, Pedro RN, Mahklouf A, et al. Roux-en-Y gastric bypass is associated with early increased risk factors for development of caclium oxalate nephrolithiasis. J Am Coll Surg. 2008;206:1145-1153.

    Article  PubMed  Google Scholar 

  28. McLeod RS, Churchill DN. Urolithiasis complicating inflammatory bowel disease. J Urol. 1992;148:974-978.

    CAS  PubMed  Google Scholar 

  29. Siener R, Ebert D, Hesse A. Urinary oaxalate excretion in female calcium oxalate stone formers with and without a history of recurrrent urinary tract infections. Urol Res. 2001;29:245-248.

    Article  CAS  PubMed  Google Scholar 

  30. Allison MJ, Cook HM, Milne DB, et al. Oxalate degradation by gastrointestinal bacteria from humans. J Nutr. 1986;116:455-460.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bernhard Hess .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer London

About this chapter

Cite this chapter

Hess, B. (2010). Obesity, Metabolic Syndrome, and Stones. In: Rao, N., Preminger, G., Kavanagh, J. (eds) Urinary Tract Stone Disease. Springer, London. https://doi.org/10.1007/978-1-84800-362-0_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-84800-362-0_9

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84800-361-3

  • Online ISBN: 978-1-84800-362-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics